Skip to main content

Turner Kathy V's Form 4 filing

IDEXX Laboratories Inc (IDXX) · filed Feb 17, 2023

Accession no.
0001567619-23-003311
Filed
Feb 17, 2023
Trade date
Feb 15-16, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $515.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Turner Kathy VCIK 0001740719Officer (Senior Vice President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 15, 2023Common StockAGrant or awardAcquired+1,000$79.54+$79,5408,379.85Direct
Feb 15, 2023Common StockSSaleDisposed−1,000$510.03F1−$510,0307,379.85Direct
Feb 16, 2023Common StockMOption exerciseAcquired+10$79.54+$795.47,389.85Direct
Feb 16, 2023Common StockSSaleDisposed−10$515.58−$5,155.87,379.85Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 15, 2023Common StockMOption exerciseDisposed−1,000–F4–3,736Direct
Feb 16, 2023Common StockMOption exerciseDisposed−10–F4–3,726Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Not applicable.

Referenced by the price of 2 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)